Leinonen Esa, Kampman Olli
TAYS, psykiatria, PL 2000, 33521 Tampere.
Duodecim. 2010;126(15):1785-92.
Comorbid disorders such as anxiety disorders, ADHD and substance-related disorders are common in bipolar patients. Comorbidity impairs the functional capacity, quality of life and prognosis in these patients. Psychiatric drug treatments of comorbid disorders are challenging as they may induce rapid-cycling and mania, thus worsening the outcome. Generally, the therapeutic requirements of the most severe disorders, i.e. bipolar disorder, are prioritized. In some cases the drug treatments of comorbid disorders are justified only after optimizing the therapy of bipolar disorder.
共病障碍，如焦虑症、注意力缺陷多动障碍和物质相关障碍，在双相情感障碍患者中很常见。共病会损害这些患者的功能能力、生活质量和预后。共病障碍的精神药物治疗具有挑战性，因为它们可能诱发快速循环和躁狂，从而使病情恶化。一般来说，最严重的疾病，即双相情感障碍的治疗需求具有优先性。在某些情况下，只有在优化双相情感障碍的治疗后，共病障碍的药物治疗才是合理的。
